They randomized 3630 survivors of MI (mean age, 60; maximum age, 74; mean LV ejection fraction, 52%) to warfarin (target INR, 2.8-4.2); aspirin (160 mg/day); or aspirin (75 mg/day) plus warfarin ...
In patients with AF, apixaban is more effective than either warfarin or aspirin for stroke prevention, with an acceptable safety profile.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback